Octagon Capital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001839435 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $904M (100.0% shares, 0.0% debt)

Holdings (29)

DNTH DIANTHUS THERAPEUTICS INC 18.1%
Value $163M Shares 1,946,667 Est. Cost $20.69 Unrealized +130.0%
COGT COGENT BIOSCIENCES INC 10.0%
Value $90.45M Shares 2,350,000 Est. Cost $9.93 Unrealized +276.1%
ABVX ABIVAX SA 8.3%
Value $75.38M Shares 677,000 Est. Cost $9.73 Unrealized —
ALMS ALUMIS INC 6.9%
Value $62.36M Shares 2,830,700 Est. Cost $8.82 Unrealized +175.8%
DFTX DEFINIUM THERAPEUTICS INC 5.1%
Value $46.12M Shares 2,440,000 Est. Cost $16.29 Unrealized 0.0%
AVBP ARRIVENT BIOPHARMA INC 5.0%
Value $45.47M Shares 1,971,054 Est. Cost $20.71 Unrealized +6.5%
TSHA TAYSHA GENE THERAPIES INC 4.4%
Value $39.6M Shares 8,859,911 Est. Cost $2.19 Unrealized +117.8%
KYMR KYMERA THERAPEUTICS INC 3.9%
Value $35.4M Shares 425,000 Est. Cost $47.13 Unrealized +64.6%
MIRM MIRUM PHARMACEUTICALS INC 3.5%
Value $31.31M Shares 338,900 Est. Cost $96.57 Unrealized 0.0%
BIOA BIOAGE LABS INC 3.4%
Value $30.57M Shares 1,748,000 Est. Cost $9.75 Unrealized +96.9%
CNTA CENTESSA PHARMACEUTICALS PLC 3.3%
Value $29.79M Shares 750,000 Est. Cost $7.34 Unrealized —
KALV KALVISTA PHARMACEUTICALS INC 3.2%
Value $29.19M Shares 1,450,000 Est. Cost $10.98 Unrealized +41.1%
XENE XENON PHARMACEUTICALS INC 3.2%
Value $28.49M Shares 490,000 Est. Cost $41.98 Unrealized 0.0%
TERN TERNS PHARMACEUTICALS INC 3.1%
Value $27.94M Shares 530,000 Est. Cost $37.46 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 3.0%
Value $26.82M Shares 3,166,600 Est. Cost $7.87 Unrealized +24.9%
PALI PALISADE BIO INC 2.0%
Value $17.98M Shares 10,276,317 Est. Cost $1.91 Unrealized -6.7%
TRVI TREVI THERAPEUTICS INC 2.0%
Value $17.72M Shares 1,485,000 Est. Cost $4.91 Unrealized +122.9%
IRON DISC MEDICINE INC 1.9%
Value $17.26M Shares 270,000 Est. Cost $74.04 Unrealized 0.0%
AKTS AKTIS ONCOLOGY INC 1.9%
Value $17.19M Shares 960,847 Est. Cost $17.89 Unrealized —
CNTX CONTEXT THERAPEUTICS INC 1.5%
Value $13.76M Shares 5,250,000 Est. Cost $2.05 Unrealized 0.0%
DTIL PRECISION BIOSCIENCES INC 1.4%
Value $12.3M Shares 2,236,732 Est. Cost $5.44 Unrealized -26.5%
DBVT DBV TECHNOLOGIES S A 1.3%
Value $12M Shares 574,200 Est. Cost $9.15 Unrealized —
UNCY UNICYCIVE THERAPEUTICS INC 0.7%
Value $6.58M Shares 1,000,000 Est. Cost $6.18 Unrealized +3.7%
BBOT BRIDGEBIO ONCOLOGY THERAPEUT 0.7%
Value $6.435M Shares 719,000 Est. Cost $11.58 Unrealized —
LXEO LEXEO THERAPEUTICS INC 0.7%
Value $6.314M Shares 1,100,000 Est. Cost $9.13 Unrealized -17.4%
PHVS PHARVARIS N V 0.5%
Value $4.661M Shares 165,000 Est. Cost $18.98 Unrealized +40.9%
CATX PERSPECTIVE THERAPEUTICS INC 0.4%
Value $3.301M Shares 791,555 Est. Cost $3.84 Unrealized 0.0%
EVMN EVOMMUNE INC 0.4%
Value $3.298M Shares 143,472 Est. Cost $18.78 Unrealized +17.1%
GOSS GOSSAMER BIO INC 0.3%
Value $2.546M Shares 7,750,000 Est. Cost $1.89 Unrealized +19.2%